Early HIV treatment key to avoiding brain atrophy


While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment. A new study underscores the neurological consequences of exposure to HIV without antiretroviral therapy.

Low-income HIV patients suffer with healthcare access


Researchers have observed that HIV-infected persons who count on social assistance and other income security programs in Quebec do not have early access to anti-retroviral treatment (ART) for HIV and AIDS due to their presumed lower socio-economic status.

The neuroscience of HIV

Entre Nous

On World AIDS Day, Dr. Lesley Fellows discusses Positive Brain Health Now, a major study to better understand the effects of HIV infection on brain health.

“Together, we can stop HIV and AIDS,” says incoming Osler lecturer

Entre Nous

In advance of his Osler Lecture on Oct. 26, renowned HIV/AIDS expert, Dr. Julio Montaner tells the McGill Reporter that an AIDS-free world is possible by the year 2030 and discusses what ordinary Canadians can do to fight the global pandemic.

Preventable deaths of children with HIV


According to the World Health Organization, 150,000 children with HIV under 15 years of age died of opportunistic infections in low-to-middle income countries in 2014 alone. But a new study suggests that many of these infections and deaths potentially preventable had the children received antiretroviral therapy to support their depleted immune systems.

United against AIDS

Around Campus

At the McGill University Health Centre (MUHC) and the Research Institute of the MUHC, our researchers, doctors, students and employees are all contributing in their own ways to halting the spread of HIV and offering the best possible care to those who are affected by the disease, bringing them hope and comfort. Here are some of their faces and messages.

In conversation with Dr. Marina Klein, co-infection researcher

Entre Nous

On this, World AIDS Day (Dec. 1), the Reporter spoke to Dr. Marina Klein about her research on patients with HIV and chronic hepatitis – a particularly virulent combination that effects more than 20,000 Canadians and millions more worldwide. According to Dr. Klein, the key to treating these patients lies just as much in education and social programs as it does in antiretroviral pharmaceuticals.

World first: Launch of Quebec registry for users of medical cannabis

Other News

The Research Institute of the McGill University Health Centre and the Canadian Consortium for the Investigation of Cannabinoids have launched a registry for users of medical cannabis in Quebec that will allow physicians to better manage its use and monitor patient safety. This innovative project represents the world’s first research database on the use of cannabis for medical purposes and places the province at the forefront of research in the field of medical cannabis.